News Letter
Information about Prostate Cancer

 

Prostate cancer is  a cancer in male prostate, a small walnut shaped gland that produces seminal fluid. There are different types of cells in prostate gland but mostly cancer develop in cells called Adenocarcinoma. Prostate cancer is the most common cancer in males, comprising 32% of all the cancers. Prostate cancer is uncommon in men under 50 years of age, the incidence increases in men over 60 years and peaks in men around 80 years of age.

 

Epidemiological studies estimated that overall cancer rates are much lower in India than in western countries. U.S. Men get 23 times more prostate cancer than men in India.

 

 

Prostate cancer is one of the cancer which responds very favorably to Rasayana Therapy. Patients both in initial stages and in advanced stages of disease show very promising results which are validated by PET/Bone scans.

 

Our main approach in Prostate cancer starts with providing Rasayana to strengthen the functions of the Genito-urinary system. Rasayana also is prescribed to protect other tissues and organs especially the bones from metastasis. Rasayana Therapy helps in restoring normal functioning of the patients even in advanced stages. Even patients with multiple skeletal metastasis are able to comfortably lead there life without requirement of any analgesics. Rasayana Therapy significantly reduces the risk of pathological fractures in such patients.

 

We have several patients treated with Rasayana who has showed outcomes like tumor regression, regression of skeletal metastasis and more than 8 years of disease free survival even at very advanced stage.

 

The presenting symptoms of Prostate cancer depend of extent of disease. Localized and invasive Prostate cancer symptoms are as follows :

 

Local disease

 

1.      Reduced void pressure.

2.      Hesitancy.

3.      Post micturition dribbling.

4.      Frequency increase.

5.      Urgency in urination.

6.      Nocturia.

 

Locally invasive disease

 

1.      Perineal Pain.

2.      Tenesmus.

3.      Impotence.

4.      Incontinence.

5.      Heamatospermia.

6.      Loin pain.

7.      Anuria from ureteric obstruction.

 

Metastatic disease

 

1.      Bone pain.

2.      Sciatica/paraplegia.

3.      Pathological fracture.

4.      Lymphoedema.

 

Widespread disease

 

1.      Anaemia.

2.      Uraemia.

3.      Weight Loss.

4.      Lethargy. 

 

1. Age

Strongest risk factor .Present in 70% of men at 80 years age

 

2. Race

High incidence in N.Europe, N.America. Low in Indian than western countries

 

3. Genetic

2-3 fold increase if first degree relative affected. About 10 % cases of cases can be occurred by the inheritance of autosomal dominant genes

 

4. Androgens

Rare in male castrated before puberty. Rare if deficient in5 α-reductase

 

5. Implicated Risk Factors

 

6. Western Diet

High incidence if diet rich in fat and red meat consumption. Low if rich in Vitamin A

 

7. Environmental

Industrial chemicals, cadmium and nuclear industry workers may be at increased risk

 

8. Vasectomy

A slight relative risk of developing prostate cancer has been reported but the link is unproven 

 

The diagnosis of Prostate cancer is established by transurethral, rectal, or perineal biopsy.

 

Investigations for Prostate cancer

Digital Rectal examination (DRE) - DRE provides information on size of the prostate and detects changes as induration, firmness, nodules and extracapsular extension. The test is limited, as the accuracy of information is examiner dependent.

Prostate specific antigen

PSA is a glycoprotein and is secreted by prostatic cells. The normal serum value is between 0 and 4 ng/ml. PSA can be used in detection and staging of Prostate cancer and also used as a marker to monitor patients with cancer both before and after therapy.

Transrectal Ultrasound (TRUS)

A specially designed ultrasound probe is inserted into the rectum to image the prostate.The main use of TRUS is as guide for transrectal biopsy of the Prostate to determine the Gleason grade.

Computerized tomography and magnetic resonance imaging (MRI)

It can be used to identify spread of disease to other organs.

Bone scanning

Radio labelled bone scanning is a sensitive and specific method of detecting metastatic deposits.

 

1. Watchful waiting – Patients with well differentiated localized cancer who are elderly or have significant co-morbidity should be considered for conservative observations and treated if there is disease progression.

 

2. Radical prostatectomy- It involves removal of the prostate and seminal vesicles, is associated with significant morbidity (incontinence, impotence)for patients with stage T1-T2 disease.

 

3. Radiotherapy-In patients who would not be suitable for surgery but have good life expectancy and localized diseases should be considered for radiotherapy. It may involve Brachytherapy or EBRT.

 

4. Hormonal therapy- Patients with locally advanced and metastatic disease may be treated with hormonal therapy.

Global Appointment
Dubai

Dr. Bendale will be soon available at Dubai for offering consultation to patients.Patients desirous of having an appointment can contact us at following mail id care@rasayucancerclinic.com

Netherland and Belgium

Dr. Bendale will be soon available at Netherland for offering consultation to patients.Patients desirous of having an appointment can contact us at following mail id care@rasayucancerclinic.com

London

Dr. Bendale will be soon available at London for offering consultation to patients.Patients desirous of having an appointment can contact us at following mail id care@rasayucancerclinic.com